about
Type I interferons for induction of remission in ulcerative colitisThe intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directionsFecal microbiota transplantation: in perspectiveVedolizumab: an α4β7 integrin antagonist for ulcerative colitis and Crohn's diseaseClassical and recent advances in the treatment of inflammatory bowel diseasesMolecular mechanism of action of anti-tumor necrosis factor antibodies in inflammatory bowel diseasesRecent advances in orally administered cell-specific nanotherapeutics for inflammatory bowel diseasePathophysiological role of guanylate-binding proteins in gastrointestinal diseasesATG16L1: A multifunctional susceptibility factor in Crohn diseaseDrug Metabolism by the Host and Gut Microbiota: A Partnership or Rivalry?Differing Complex Microbiota Alter Disease Severity of the IL-10-/- Mouse Model of Inflammatory Bowel Disease.Richness and diversity of mammalian fungal communities shape innate and adaptive immunity in health and disease.From historical perspectives to modern therapy: a review of current and future biological treatments for Crohn's diseaseExperimental colitis in mice is attenuated by topical administration of chlorogenic acid.Interferon Gamma Counteracts the Angiogenic Switch and Induces Vascular Permeability in Dextran Sulfate Sodium Colitis in Mice.Characterization of Serum Cytokine Profile in Predominantly Colonic Inflammatory Bowel Disease to Delineate Ulcerative and Crohn's Colitides.A zebrafish model of inflammatory lymphangiogenesisTherapeutic effects of mouse bone marrow-derived clonal mesenchymal stem cells in a mouse model of inflammatory bowel disease.The effect of sphingosine-1-phosphate on colonic smooth muscle contractility: Modulation by TNBS-induced colitisThe implications of oxidative stress and antioxidant therapies in Inflammatory Bowel Disease: Clinical aspects and animal models.The REGγ-proteasome forms a regulatory circuit with IκBɛ and NFκB in experimental colitisOral Manifestations of Inflammatory Bowel Diseases: Two Case Reports.Serotonin-Exacerbated DSS-Induced Colitis Is Associated with Increase in MMP-3 and MMP-9 Expression in the Mouse Colon.JAK inhibition using tofacitinib for inflammatory bowel disease treatment: a hub for multiple inflammatory cytokinesTLR2-Dependent Signaling for IL-15 Production Is Essential for the Homeostasis of Intestinal Intraepithelial Lymphocytes.miRNA-133a-UCP2 pathway regulates inflammatory bowel disease progress by influencing inflammation, oxidative stress and energy metabolism.Mechanisms of Intestinal Epithelial Barrier Dysfunction by Adherent-Invasive Escherichia coli.Identification of Candidate Genes Related to Inflammatory Bowel Disease Using Minimum Redundancy Maximum Relevance, Incremental Feature Selection, and the Shortest-Path Approach.Stressor exposure has prolonged effects on colonic microbial community structure in Citrobacter rodentium-challenged mice.Animal models of inflammatory bowel disease: a review.Mucus layers in inflammatory bowel disease.Proteins and peptides: The need to improve them as promising therapeutics for ulcerative colitis.Orofacial granulomatosis: clinical signs of different pathologies.Therapeutic potential of tonsil-derived mesenchymal stem cells in dextran sulfate sodium-induced experimental murine colitisMolecular Alterations of Colorectal Cancer with Inflammatory Bowel Disease.The Anti-Inflammatory Effect of Guchangzhixie-Pill by Reducing Colonic EC Cell Hyperplasia and Serotonin Availability in an Ulcerative Colitis Rat Model.Inflammatory Bowel Disease: Genetics, Epigenetics, and Pathogenesis.The impact of inflammatory bowel disease on oral health.Anti-inflammatory effect of cannabinoid agonist WIN55, 212 on mouse experimental colitis is related to inhibition of p38MAPK.Tofacitinib for the treatment of ulcerative colitis.
P2860
Q24187202-62FD63CF-FDB7-49C5-9CE1-465D24344BE8Q26745700-AA0E8334-1CD1-4A74-8AA5-EBB37B285027Q26765214-5093CAF3-7718-49E2-A778-DB383F52404DQ26786018-36C22130-BEA9-4AF5-ACBA-CF605E2FBFBBQ26861725-11FF6755-7D43-4145-86A5-A6F5D5B0C11EQ28067245-8BCE672F-6A54-42D4-9364-AF8121B13F1BQ28073219-435A8962-CE6C-446C-BF82-ECCA98C03CF7Q28078361-E6DF8E11-5BB4-4275-951F-51C9B45D8D2CQ28082887-D320BDB7-8943-4AB0-82D5-6F306412E79AQ28607457-E227EE54-46B8-4E03-8FDB-F4FCD64A78BDQ33658943-14BB4E40-4433-4AC8-9424-BAC3B326896DQ35278095-5F1D76EC-DB9F-4A34-AAAB-E72A264C2FBFQ35559305-D531EE34-AF15-499F-A250-8BDE2F432947Q35626127-974ACBDD-F200-4475-B377-037EF2A7E607Q35688870-AD552033-4A7D-457F-B21D-473A468EC3A4Q35694271-DC0CBE58-3269-4BC6-A840-FF8EC3FADA41Q36175340-9515D728-D71C-427E-A9D9-DBC342151ABDQ36265369-1CF95B9C-6A99-4AB7-951B-0E816FEEE2DAQ36368910-D1A21158-AEA4-42DB-9DBD-27DE9FFCB20CQ36606775-7D66C041-8B7D-4459-83BF-E0CBE2507721Q36611102-5FF30451-A7B0-43D0-8332-B1293EBF787EQ36852795-29C6A5BC-58D3-45E7-A194-5B805C2C2803Q37104745-7318C9F6-1CC6-4A15-8A03-1B9020682920Q37148745-5F4B19EC-2522-4041-B510-A914D2C34B8AQ37172678-B684C42B-E77E-47AE-B2DD-7F86867420D5Q37572580-315643B5-F2C4-4BCF-98FB-82BB9E000F78Q37594944-70057689-FB92-40B7-90F2-C8DE20D7BB40Q37672624-7FD1CA83-6BB6-4438-94B7-5BC07E83D203Q37721486-6E944559-C2F2-4D9A-8B29-99798ACB7B89Q38218335-A19A8511-70F1-4C29-8AF6-D2040115188BQ38229690-2370CE21-EFB6-421C-A061-2CB12939CE50Q38266101-59F0F5A1-879F-4A8F-9B13-4F61B1FE0DD9Q38319964-6B120E30-4F94-4A28-99AA-A791DFB14B6BQ38399146-7EB4869F-448A-4A73-95A1-56937F27408EQ38404877-5D295D48-76FB-4957-8008-BA472B7D1F0BQ38606277-75C63383-6951-479F-8040-915A69F5064CQ38636847-EE6E4075-2A11-4CA8-9437-DD963EF01DA8Q38733734-39DF3D07-C88E-4EB3-A3E3-5FDBB2926014Q38786805-BCA1772E-EABE-4EF9-AD08-1851AA9EA9D5Q38833865-46FDC5A7-52E9-4E3C-BA98-4237953534B4
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Inflammatory bowel disease: pathogenesis.
@en
Inflammatory bowel disease: pathogenesis.
@nl
type
label
Inflammatory bowel disease: pathogenesis.
@en
Inflammatory bowel disease: pathogenesis.
@nl
prefLabel
Inflammatory bowel disease: pathogenesis.
@en
Inflammatory bowel disease: pathogenesis.
@nl
P2860
P921
P356
P1476
Inflammatory bowel disease: pathogenesis.
@en
P2093
Yi-Zhen Zhang
Yong-Yu Li
P2860
P356
10.3748/WJG.V20.I1.91
P407
P577
2014-01-01T00:00:00Z